T cells expressing an invariant TCR a chain and NK cell markers are expected to exhibit unique functions. Whereas much attention has been paid to CD1d-restricted NKT cells, a second NKT cell population bearing an invariant AV19±AJ33 TCR has recently been identi®ed in mice and humans. Selection and/or expansion of this population require B cells, and would involve a non-classical class I-related molecule MR1. Although their preferential distribution in the gut mucosa indicates their role in the host response at the site of pathogen entry, it remains unknown whether they play an alternative role at different sites or in immunological disorders. Using single-strand conformation polymorphism clonotype analysis, we investigated the presence of the human AV19±AJ33 T cells (V a 7.2±J a 33 T cells) in autopsy samples from multiple sclerosis (MS) patients as well as in nerve biopsy samples from chronic in¯ammatory demyelinating polyneuropathy (CIDP) patients. Here we report that the V a 7.2±J a 33 T cells are accumulated in some of the central nervous system lesions of MS and in the majority of the peripheral nerve samples from CIDP. We have previously revealed that CD1d-restricted, V a 24±J a Q NKT cells are remarkably reduced in the peripheral blood from MS. However, V a 7.2±J a 33 T cells are not reduced in the peripheral blood from MS and could be detected in a large majority of the cerebrospinal¯uid samples obtained during relapse of MS. The present results indicate that the V a 7.2±J a 33 T cells are involved in the autoimmune in¯ammatory lesions.
Introduction
Conventional T cells display a wide and diverse repertoire with regard to TCR that are made by random recombination of V, D and J segments as well as junctional deletion and insertion of nucleotides. In addition to these mainstream T cells that have undergone thymic selection for cognate peptides bound to MHC molecules, there also exist discrete`invariant' lymphocyte populations, characterized by limited repertoire diversity due to their expression of an invariant receptor chain (1) . The most well-characterized`invariant' T cells are CD1d-rectricted NKT cells, which constitute a major component of lymphocyte populations expressing TCR and NK cell markers. The NKT cells are reactive to glycolipid presented by CD1d molecules and express an invariant TCR a chain paired with particular V b segments [V a 24±J a Q a chain paired with V b 11 in humans; V a 14±J a 281 with V b 8.2 and 7 in rodents] (2±4). Although the natural ligand for the CD1d-restricted NKT cells still remains unknown, they could produce large amounts of cytokines shortly after TCR ligation, allowing us to speculate that they play a critical role in regulation of various immune responses that would maintain the state of health or cause damage to self-tissues.
Several lines of evidence indicate that the T cell repertoire in humans contains`invariant' T cells distinct from CD1d-restricted NKT cells (2,5±7) . It has recently been proposed that T cells expressing an invariant AV19±AJ33 TCR (the canonical hV a 7.2±J a 33 or mV a 19±J a 33 TCR rearrangement) represent a second`invariant' T cell subset that would develop in the absence of CD1d (8±11). Independent studies by Lantz et al. (8, 11) and Shimamura et al. (9, 10) have shown that the V a 19±J a 33 T cells do not require CD1d for their development and expansion in vivo. They are present in TAP-1 knockout mice (8) , but are absent in b 2 -microglobulin-de®cient mice (8, 9) , suggesting that they probably recognize a non-peptide antigen associated with a non-classical MHC class Ib molecule other than CD1d. Although surface phenotypes of the invariant T cells remain to be fully characterized, the V a 19± J a 33 T cells were enriched in the NK1.1 + CD3 + population isolated from CD1d-de®cient mice (9) , allowing us to refer to the`invariant' T cells as a second type of NKT cells. Very recently, Lantz et al. (11) have reported that the`invariant' T cells are enriched in the gut lamina propria, and that their selection and/or expansion require B cells and commensal ora. The distribution of the cell population would indicate that the novel`invariant' T cells are possibly involved in the host response at the site of pathogen entry. Finally, MR1, a nonclassical class I-related molecule (12) , has been identi®ed as a restriction element involved in the selection of the V a 19±J a 33 T cells.
It is of note that the novel MR1-restricted NKT cells share several characteristics with CD1d-resticted NKT cells. For example, both of the`invariant' populations can be detected in unrelated individuals with different ethnic backgrounds and a majority of the cells resides in the CD4 ± CD8 ± T cell population (7, 8) . As noted, the TCR a chain represents the canonical V a ±J a rearrangement, whereas the b chain sequence is restricted by the use of particular V b segments (hV b 11 for CD1d-restricted NKT cells and hV b 2 and 13 for MR1-restricted T cells). Both of the`invariant' populations have a`natural' memory phenotype (CD44 high ). Furthermore, the invariant TCR sequences as well as their restriction elements (CD1d and MR1) are highly conserved across the species. These characteristics are consistent with the idea that the`invariant' lymphocyte populations might exert an immediate response against phylogenetically conserved antigens at the frontier between innate and adaptive immunity (1) . In accordance with this idea, CD1d-restricted NKT cells produce large amounts of IL-4 and IFN-g within hours of TCR engagement (3,13±15) . Through the explosive release of cytokines and chemokines, they are capable of initiating a cascade of immunological events involved in regulation of autoimmunity and vital defense against microbial agents or tumor cells (1) . In contrast, very little is known about the function of the MR1-resricted T cells. Although accumulating data indicate that they may promptly respond to antigen by producing IL-4 (Shimamura et al., unpublished observations), their ability to produce cytokines and chemokines needs to be systematically analyzed in the coming years.
A numerical reduction or functional alterations in CD1d-rectricted NKT cells bearing the V a 24±J a Q invariant chain have been documented in various human autoimmune diseases (3,4). Using three different approaches, the RT-PCR single-strand conformation polymorphism (SSCP) clonotype method (16) , anti-V a 24 and anti-V b 11 antibodies, and glycolipid-loaded CD1d tetramers (17), we have recently revealed that the V a 24±J a Q NKT cells are greatly reduced in number in the peripheral blood of multiple sclerosis (MS), a putative autoimmune disease mediated by T h 1 autoimmune T cells (18, 19) . We also examined the distribution of the V a 24±J a Q NKT cells in the central nervous system (CNS) lesions from patients with MS as well as in the peripheral nerve biopsy samples derived from chronic in¯ammatory demyelinating polyneuropathy (CIDP) patients (16) . Although expression of non-invariant V a 24 rearrangement was ubiquitous in the CNS samples of MS, the V a 24±J a Q clonotype speci®c for the NKT cells appeared to be missing in most of the CNS lesions. In contrast, the NKT cell clonotype could be readily detected in a large majority of the biopsy samples of CIDP, which is a chronic demyelinating disease of the peripheral nervous system (PNS) with a presumed autoimmune origin (20) .
Using the same samples previously analyzed for the V a 24± J a Q NKT cells (16), we conducted experiments to address the following questions. (i) Are the invariant V a 7.2±J a 33 T cells reduced in the peripheral blood of MS? (ii) Are they involved in the in¯ammatory lesions of MS and CIDP or could they be missing from the lesions? (iii) Are they present in the cerebrospinal¯uid (CSF) derived from MS? Here, we report that unlike the V a 24±J a Q NKT cells, the V a 7.2±J a 33 T cells are not reduced in the peripheral blood of MS. More strikingly, they were detected in some of the pathological samples obtained from MS and in the majority of nerve biopsy samples from CIDP, and could be detected in the CSF samples from MS. Comparison with other T cell populations indicated a selective accumulation of the V a 7.2±J a 33 T cells in the in¯ammatory lesions. We propose that the invariant V a 7.2± J a 33 T cells do not only play a role in protection against pathogen entry in the gut (11) , but also in the regulation of autoimmune tissue in¯ammation.
Methods

Selection of patients with MS or CIDP
We obtained peripheral blood and CSF from patients with de®nite MS' according to the diagnostic criteria proposed by Poser et al. (21) . The diagnosis of MS was further assisted by magnetic resonance imaging and evoked responses. All patients had remitting-relapsing MS and did not receive immunosuppressive agents at the time of investigation. Diagnosis of CIDP was based on the criteria of the American Academy of Neurology (22) .
Peripheral blood mononuclear cells (PBMC), CSF, CNS and PNS samples
Heparinized blood (20 ml) was taken and PBMC were isolated by Ficoll density gradient centrifugation. CSF samples were obtained within 1 week after the onset of exacerbation. The sural nerve biopsy samples were taken for other diagnostic purposes with standard procedure (23) . Samples were snapfrozen and were stored at ±70°C along with frozen brain samples until analysis had been performed. The histopatho-at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from logical characterization of the MS plaques was performed as described previously (24) .
Isolation of mRNA and synthesis of cDNA mRNAs were isolated from 10 7 PBMC and from CSF sediment using the QuickPrep Micro mRNA puri®cation kit (AmershamPharmacia Biotech, Uppsala, Sweden). The air-dried pellet was resuspended in 20 ml of RNase-Free Water and used for cDNA synthesis by the First-Strand cDNA synthesis kit (Amersham-Pharmacia Biotech, Uppsala, Sweden) using oligo-dT as primer. The mRNAs previously isolated from autopsy CNS samples and sural nerve biopsy samples (16) were also converted to cDNA by the same approach.
SSCP analysis
We conducted RT-PCR SSCP following ampli®cation with V a and C a primers as described previously (16, 25) . Primers and probes were designed based on the previously published sequences (2, 3, 5, 8, 26) . To detect the V a 7.2±J a 33 invariant chain, 1 ml of the diluted cDNA was used for each PCR reaction with V a 7.2-speci®c sense primer (GTCGGTCTAAAGGGTA-CAGT) and anti-sense C a -speci®c primer (CAGCTGAGAG-ACTCTAAAT). cDNAs obtained from PBMC samples were ampli®ed by PCR for 39 cycles, while cDNAs from autopsy/ biopsy samples and CSF were ampli®ed for 40 cycles. Quantities of 0.2 mg of sense and 0.2 mg of anti-sense primers (30 pmol) were added to 50-ml reactions containing 5 ml of 10 Q ExTaqBuffer, dNTPs and 2.5 U of ExTaq DNA polymerase (Takara, Tokyo, Japan). Ampli®ed DNAs were diluted (1:3) and heat-denatured. Aliquots of 4 ml of the diluted samples were electrophoresed in non-denaturing 4% polyacrylamide gel. DNAs were transferred to Immobilon-S (Millipore Intertech, Bedford, MA) and hybridized with biotinylated C aspeci®c (AAATATCCAGAACCCTGACCCTGCCGTGTACC), J a 33-speci®c (TATCAGTTAATCTGGGGCGCTGGGACCAA-GCT) or invariant V a 7.2±J a 33-speci®c internal probe (TGTGC-TGTGAGAGATAGCAACTATCAGTTAATCTG). To detect the V a 24±J a Q invariant chain, cDNAs were PCR ampli®ed with V a 24-speci®c sense primer (ACACAAAGTCGAACGGAAG) and C a -speci®c anti-sense primer (GATTTAGAGTCTCTCA-GCTG), and then hybridized with a probe speci®c for the invariant V a 24±J a Q sequence (TGTGTGGTGAGCGACAGAG-GCTCAACCCTG) as previously described (16) . SSCP clonotypes were visualized by incubation with streptavidin, biotinylated alkaline phosphatase and a chemiluminescent substrate system (Phototope; New England Biolabs, Bedford, MA). cDNAs for human IL-4 and IFN-g were ampli®ed by RT-PCR as described previously (16) .
Real-time V a 7.2 clonotypic RT-PCR
Quantitative RT-PCR (LightCycler; Roche Molecular Biochemicals, Mannheim, Germany) was performed with the V a 7.2 sense primer and with an anti-sense primer matching the CDR3a region of the V a 7.2±J a 33 T cells (TGATAGTTG-CTATCTCTCAC). An aliquot of 1 ml of the cDNA was ampli®ed by PCR for 40 cycles using quanti®cation with a commercial kit (LightCycler DNA Master SYBR Green I; Roche Molecular Biochemicals). Quantities of 0.2 mg of sense and 0.2 mg of antisense primers (30 pmol) were added to 50-ml reactions containing 5 ml of 10 Q ExTaqBuffer, dNTPs and 2.5 U of ExTaq DNA polymerase (Takara). All PCR reactions were controlled by b-actin expression (sense primer: AGAGA-TGGCCACGGCTGCTT; anti-sense primer: ATTTGCGGTGG-ACGATGGAG) (27) . Based on the standard values of control samples, the relative expression for each sample was determined with the LightCycler software.
TCR DNA sequencing
In brief, small areas of the SSCP gel corresponding to the clonotypes of interest were cut out and DNAs were eluted as described previously (25) . A second PCR was performed with the corresponding V a -speci®c and C a -speci®c primers using the eluted DNAs as template. The PCR products were cloned into pCR 2.1-TOPO Vector using TOPO TA cloning kit (Invitrogen, Carlsbad, CA) and recombinants were sequenced using an ABI 377 DNA sequencer (Applied Biosystems, Foster City, CA).
Results
Invariant V a 7.2±J a 33 T cells represent a dominant V a 7.2 + subset in the peripheral blood of healthy subjects (HS) First, we examined if the RT-PCR SSCP clonotype method (16, 25, 28, 29) could be used to detect the invariant V a 7.2±J a 33 sequence in peripheral blood derived from HS. Following mRNA isolation from nine PBMC samples, the TCR a chain sequences encompassing the aCDR3 region were RT-PCR ampli®ed with a set of V a 7.2 and C a primers. The ampli®ed cDNAs were denatured and electrophoresed on the SSCP gel, and hybridized with C a -, J a 33-or invariant V a 7.2±J a 33-speci®c probe. Hybridization with the C a probe has revealed several bands in the smear background on the gel, indicating that T cells using the V a 7.2 segment are restricted, but heterogeneous ( Fig. 1, upper panel) . However, hybridizing with the J a 33 probe revealed a solitary band in each sample at a same position (Fig. 1, middle panel) , indicating that a single clonotype may dominate the TCR V a 7.2 and J a 33 rearrangements found in the peripheral blood. Given that the invariant V a 7.2±J a 33 clonotype was identi®ed as an expanded clonotype in prior studies (7, 8) , we speculated that the solitary band that hybridized with the J a 33-speci®c probe might correspond to the invariant V a 7.2±J a 33 sequence. Consistent with this speculation, the invariant V a 7.2±J a 33-speci®c probe detected a distinct band at the same position where the J a 33-speci®c probe hybridized (Fig. 1, lower panel) .
To con®rm if the clonotype hybridized with the J a 33-speci®c probe represents the invariant V a 7.2±J a 33, we eluted DNA from the sites of the gel corresponding to the band, and ampli®ed the DNA by a second PCR with V a 7.2 and C a primers. The ampli®ed cDNAs were cloned and 10±15 clones from each individual were sequenced. Analysis of four randomly selected HS has shown that 70±90% of the clones from each subject possess the V a 7.2±J a 33 invariant sequence (GTG AGA) in the CDR3 region. Another CDR3 DNA sequence (GTG ATG combined with J a 33) was detected repeatedly in two of the four individuals. However, all the other sequences differed from each other and were not shared by different individuals. This analysis assured that the solitary band of our Invariant V a 7.2±J a 33 T cells do not expand in response to a-galactosylceramide (a-GalCer) V a 24±V a 11 NKT cells are known to proliferate in response to aGalCer, which is a prototype ligand for the NKT cells (4, 17) . Additionally, we examined if the invariant V a 7.2±J a 33 T cells respond to a-GalCer. In brief, PBMC from healthy individuals were stimulated with a-GalCer as previously described (17) and the a-GalCer-stimulated PBMC cultures were harvested at different time points for SSCP analysis. We observed that the invariant V a 7.2±J a 33 clonotype would gradually diminish, while the V a 24±V a 11 clonotype remarkably expanded shortly after stimulation with a-GalCer (data not shown). This result con®rms that a-GalCer is not a stimulatory ligand for the invariant V a 7.2±J a 33 T cells.
Invariant V a 7.2±J a 33 T cells are not reduced in the peripheral blood of MS In previous studies, we have demonstrated that the V a 24±J a Q NKT cells are remarkably reduced in the peripheral blood of MS, particularly in the remission phase (16, 17) . In fact, SSCP analysis for the V a 24±J a Q clonotype detected the NKT cell clonotype in all the HS (18 of 18, 100%) (16), but the clonotype was not found in any of the MS patients in remission (Table 1) .
Given the notable similarities between CD1d-restricted NKT cells and MR1-resricted T cells, we speculated that the invariant V a 7.2±J a 33 clonotype might also be reduced in the peripheral blood of MS. However, the invariant clonotype could be readily detected by the SSCP method in 13 of 15 peripheral blood samples from MS patients in remission ( Fig. 2 and Table 1 ). To further evaluate the frequency of the V a 7.2± J a 33 T cells in PBMC of MS, we applied a real-time RT-PCR with V a 7.2-and V a 7.2±J a 33 clonotype-speci®c primers for quantitative analysis. Using this assay, we measured relative expression of the invariant V a 7.2±J a 33 mRNA in the PBMC derived from ®ve MS in remission and from ®ve HS. As shown in Fig. 3 , there was no signi®cant difference between HS and the patients with MS. Taken together, we conclude that MR1-restricted T cells are conserved in number in the patients with MS.
In®ltration of the invariant V a 7.2±J a 33 T cells in the CIDP lesions
We could previously demonstrate an expression of the invariant V a 24±J a Q TCR in 60% of the peripheral nerve biopsy samples from CIDP (16) . A possible interpretation was that the NKT cells may be recruited to the lesions like in¯ammatory cells (30±32). It is very interesting to know if MR1-restricted T cells are also recruited to the CIDP lesions. Here we examined the CIDP samples for their expression of the V a 7.2±J a 33 invariant sequence. We were able to amplify V a 7.2 + TCR messages from all the 10 samples. Hybridization with the C aspeci®c probe (Fig. 4A ) revealed a number of bands in every lesion, suggesting that not only the invariant V a 7.2±J a 33, but conventional V a 7.2 + , T cells may also be present in the lesions. Hybridization with J a 33-or invariant V a 7.2±J a 33-speci®c probe displayed the invariant clonotype in eight out of the 10 samples (Fig. 4A , and Tables 1 and 2 ). We also examined 11 nerve biopsy samples from other neurological diseases (OND) as controls. A faint single band was found in four of the 11 OND samples after hybridization with the C a -speci®c probe (Fig. 4B) . However, none of the samples hybridized with the J a 33-speci®c probe, excluding the presence of the invariant V a 7.2±J a 33 T cells in the control PNS lesions. These results demonstrate that not only the V a 24±J a Q NKT cells, but also V a 7.2±J a 33 T cells, would preferentially accumulate in the in¯ammatory lesions of CIDP. We classi®ed the CIDP biopsy samples into four groups, based on the expression pattern of the V a 7.2±J a 33 and V a 24± J a Q invariant sequences ( Table 2) . Eight of the 10 samples belonged to Group I (V a 7.2±J a 33 + /V a 24±J a Q + ) or Group II (V a 7.2±J a 33 + /V a 24±J a Q ± ), as re¯ected by the frequent detection of the V a 7.2±J a 33 clonotype. We could consistently detect IL-4 mRNA in all the samples from Groups I and II. More interestingly, IFN-g was detected in four of ®ve samples from Group I, but detected in only one of three samples from Group II. Although the number of samples was not large enough to draw any conclusion, this may indicate a possible difference between Groups I and II with regard to the cytokine milieu.
Accumulation of the invariant V a 7.2±J a 33 T cells in the autopsy CNS lesions of MS Next we asked if the V a 7.2±J a 33 T cells may in®ltrate into the autopsy CNS lesions of MS. Using the SSCP clonotype method, we analyzed 14 CNS lesions obtained from ®ve Table 2 . (B) Sural nerve biopsy samples from patients with OND were examined by SSCP. C a -speci®c hybridization detected bands in four samples as shown here. However, the J a 33-speci®c probe did not detect any band (not shown). The OND include hereditary motor and sensory neuropathy, alcoholic polyneuropathy, acute demyelinating polyneuropathy, Churg±Strauss syndrome, POEMS syndrome, diabetic polyneuropathy, and Krabbe disease. http://intimm.oxfordjournals.org/ autopsied cases with MS, including seven acute plaques, six subacute plaques and one chronic plaque. V a 7.2 + TCR could be ampli®ed by RT-PCR from seven out of the 14 lesions, although they were detected only in one of the six control CNS samples (Table 1) . We found that all the V a 7.2 + plaques (four acute plaques, two subacute plaques and a single chronic plaque) expressed the message for the invariant V a 7.2±J a 33 sequence (Fig. 5 , upper panel and Table 1 ). In contrast, as reported previously (16) , whereas Va24 + TCR could be ampli®ed from eight of the 14 MS autopsy lesions, only a single subacute plaque expressed the V a 24±J a Q clonotype, i. e. the invasion of V a 24±J a Q NKT cells was mainly restricted to the CIDP lesions, whereas the V a 7.2±J a 33 T cells were also found in some CNS lesions from MS. To verify the postulate that the V a 7.2±J a 33 T cells are involved in the pathology of MS, we also analyzed CSF samples obtained at an acute stage of MS. We were able to detect the V a 7.2±J a 33 invariant sequence in 73% of the samples examined (Fig. 5 , lower panel and Table 1 ), supporting that the invariant V a 7.2±J a 33 T cells are a component of the CNS in®ltrates in MS.
In parallel to V a 7.2 + TCR and V a 24 + TCR, we examined the V a 19 + TCR repertoire with the SSCP method. With the C aspeci®c probe, we could detect a number of V a 19 + clonotypes in all the PBMC samples obtained from HS and MS (Table 3) . However, V a 19 + TCR was not detected in any of the CNS samples from MS or PNS samples from CIDP. This result indicates that the presence of a particular clonotype in the MS lesions does not simply re¯ect that this population is present in the peripheral circulation. In other words, it implies that the presence of the V a 7.2±J a 33 clonotype may indicate thè lesiophilic' nature of the MR1-restricted T cells.
Discussion
It has been demonstrated repeatedly that CD4 ± CD8 ± T cells in the human peripheral blood contain clonally expanded T cell populations (5±8). For example, CDR3 spectratyping analysis for the peripheral CD4 ± CD8 ± T cells in healthy individuals has previously indicated clonal expansion of T cells bearing invariant V a 7.2±J a 33, V a 4±J a 29 or V a 19±J a 48 in addition to those expressing the V a 24±J a Q NKT cell clonotype (7) . After knowing that biopsy samples of CIDP are often in®ltrated with the V a 24±J a Q NKT cells (16) , we attempted to analyze the expression of the V a 7.2±J a 33, V a 4±J a 29 and V a 19±J a 48 invariant sequences in the lesions of MS and CIDP. However, the invariant V a 4±J a 29 and V a 19±J a 48 sequences were not detected in any of the samples (data not shown). Accordingly, we focused our efforts on analysis of the V a 7.2± J a 33 T cells. In order to shed light on the difference and similarity between the V a 7.2±J a 33 and V a 24±J a Q NKT cells, we examined the autopsy and biopsy samples as well as PBMC and CSF samples previously analyzed for the expression of the V a 24±J a Q TCR (16) .
Here, we documented that the autopsy CNS lesions from MS as well as the biopsy PNS lesions from CIDP are in®ltrated with the invariant V a 7.2±J a 33 T cells. We also showed that the invariant V a 7.2±J a 33 T cells are present in a large majority of the CSF samples obtained at relapse phases of MS. In contrast, V a 19 + TCR could not be detected in any of the affected tissues from MS or CIDP after PCR ampli®cation, showed that the MR1-restricted invariant T cells are preferentially located in the gut mucosa and therefore proposed to name the population as mucosal-associated invariant T cells (MAIT). In support of the special role of this cell population in the mucosa, the number of the cells in the gut mucosa was greatly reduced in germ-free mice. This observation indicated the role of commensal¯ora for selection of the invariant T cells. Although an interpretation for this could be that the MR1-resricted T cells would recognize the exogenous antigen bound to MR1, analysis of the T±T hybridomas showed that they could recognize MR1 directly in the absence of bound ligand (11) . If this is indeed the case, the MAIT cells could be autoreactive to MR1. To accommodate the autoreactivity with the requirement for commensal¯ora, it could be speculated that MR1 expression may require some ligand derived from or induced by commensal¯ora. An alternative possibility is that microbial products may facilitate translocation of MR1 to the cell membrane.
Provided that the invariant V a 7.2±J a 33 T cells are generated or expanded in the mucosa, how would they accumulate into the in¯ammatory lesions of MS and CIDP? Although this remains a conundrum, we would speculate that in¯ammation-associated signals such as chemokines play a role in the initial step. In fact, CD1d-restricted NKT cells would behave like in¯ammatory cells and rapidly accumulate into certain granuloma lesions (30) , and they could be detected in nonautoimmune in¯ammatory lesions (31, 32) . Given a number of similarities between V a 7.2±J a 33 and V a 24±J a Q NKT cells, we would postulate that the V a 7.2±J a 33 T cells also might be preferentially recruited to the in¯ammatory sites. To support this idea, non-autoimmune in¯ammatory lesions are reported to express the invariant V a 7.2±J a 33 TCR (32) .
The second critical step may be the interaction of the invariant T cells with B cells expressing MR1 in the site of lesions, given that the vast majority of the in¯ammatory lesions are in®ltrated with B cells. We could expect the V a 7.2±J a 33 T cells to regulate local immune responses by producing cytokines. If IL-4 is the major cytokine produced by the novel invariant T cells, their interaction with B cells may lead to augmentation of antibody production. Even though the encephalitogenic T h 1 autoreactive T cells are down-regulated by IL-4, the direct interaction between B cells and the V a 7.2± J a 33 T cells may substantially augment the tissue damage or alter the type of lesions. However, if suppressive cytokines such as transforming growth factor-b are the major products of the V a 7.2±J a 33 T cells in vivo, they may down-regulate the B cells as well as in¯ammatory cells in the vicinity. Although we can only speculate about how they would deal with autoimmunity, it is possible that they would play an active role in the regulation of autoimmune in¯ammation. To verify this hypothesis, we need to systematically analyze the functions of the V a 7.2±J a 33 T cells with regard to ligand recognition and cytokine production. It is also important to know if the presence or absence of the invariant T cells may correlate with the type of pathology. The present data indicate that it is indeed a rewarding attempt.
